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co-administration with bacitracin or casein their doses were 4.0 and 10.0 mg/kg respectively. The animals were anesthetized with an intraperitoneal injection of urethane (1.5 g/kg). Blood samples (0.5 ml) were periodically taken from the orbit venous plexus at 0, 15, 30, 60, 120, 240 and 360 min using a heparinized capillary tubes and estimated by TCA-precipitable method. In another experiment, unlabeled rHV2 was administered to rats at doses of 5.0 mg/kg, while bacitracin and casein were 4.0 and 10.0mg/kg respectively. The blood sample was anticoagulated with 3.8% trisodium citrate solution in a ratio of 8.25:1.75(V/V) and the rHV2 in the plasma was determined by chromogenic assay. For the calculation of bioavailability in the two sets of experiments, 125 I-rHV2(0.5 mg/kg) and rHV2 (1.0 mg/kg) solution were given intravenously to rats by tail veins, respectively.
In situ loop experiments. The rats were anesthetized with an intraperitoneal injection of urethane (1.5 g/kg). Anesthesia was maintained with additional urethane as needed throughout the studies. The absorptions of 125 I-rHV2 from the jejunum, proximal and distal part of ileum were examined by an in situ loop method (Bai and Chang, 1995) .
Having been washed out the luminal contents, the anesthetized rats were administered the drug solution at the same doses as those used in the oral administration study. Blood samples (0.5 ml) were periodically taken from the orbital venous plexus at 0, 15, 30, 60, 120, 240 and 360 min, and determined by TCA-precipitable method.
In vitro everted sac experiments. The rats were euthenized to death with an overdose intraperitoneal injection of urethane. The segment of jejunum was excised after washing the luminal side with 20 ml of PBS (pH 7.4) (Toshikiro et al., 1996) . The isolated jejunum was everted and cut into 5-cm segments. Half a milliliter of the PBS was This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on November 10, 2003 as DOI: 10.1124 at ASPET Journals on October 26, 2017 jpet.aspetjournals.org Downloaded from JPET#56655 9 introduced into the serosal side, and both ends of the segment were ligated. The resulting everted sac was placed in the 10 ml PBS (pH 7.4) incubation media, which contained 100 µg/ml of rHV2 and 10 mg/ml casein with or without adjuvant (1mM poly-L-lysine, 1 mM Carbopol 941, 1mM DNP or 0.1 mM colchicine), and was bubbled with 95% O 2 : 5% CO 2 throughout the experiment. The incubation was performed for 30 min at 37℃, and then the everted sac was twice immersed in 20 ml of the fresh PBS (pH 7.4, 4℃) for 5 min to remove the nonspecifically adsorbed rHV2 on the mucosal surface. To remove the rHV2 bound on the membrane, the everted sac was immersed in the ice-cold basic washing solution (0.05 M NaOH/0.5 M NaCl, 10ml) for 10 min. After recovery of the serosal solution, the tissue was homogenized and mixed with 4% acetic acid. The mixture was centrifuged at 2000 × g for 10 min. The rHV2 in the resulting supernatant and in the serosal solution were determined by chromogenic assay.
Assay procedures. The 125 I-rHV2 in the blood or GI-luminal contents was determined by TCA precipitation method (Toshikiro et al., 1996) . For GI-luminal contents, 200 µl of 15% TCA was added to 200 µl of the incubation mixture, as for plasma, 1 ml of 15% TCA was added to the mixed solution after 1ml of Krebs-Henseleit bicarbonate buffer (119mM NaCl, 4.7mM KCl, 2.5mM CaCl 2 , 1.2mM MgSO 4 , 1.2mM KH 2 PO 4 , 25mM
NaHCO 3 ) containing 5% BSA was added to 50µl of each plasma sample. Afterwards, the mixtures were centrifuged at 2000 × g for 15 min, then the radioactivities in the precipitate were counted by a γ -counter (SNB-69513, Shanghai, China).
Chromogenic assay was performed according to Groetsch (Groetsch et al., 1991) with a little modification. The blood samples were denaturated by heating for 15 min at 65℃, then 0.05 ml HCl (1 M) was put into 0.5 ml blood sample. The samples were This article has not been copyedited and formatted. The final version may differ from this version. Afterwards, 16 µl chromozym TH (1.9mM) was added into the incubation mixture and kept on incubating for another 10 min at 37 ℃ . The reaction is terminated by addition of 200µl acetic acid (33%) and then the absorbance of the sample was read at 405 nm with a spectrophotometer (TU-1901, Puxi versatile instrument Co. China).
Data analysis.
The plasma concentration of rHV2 was calculated by dividing the total volume of plasma isolated. The plasma concentration-time data were analyzed non-compartmentally on the basis of the statistical moment theory. The AUC 0→360 was estimated by the trapezoidal method and the bioavailability was calculated by comparing the AUC 0→360 obtained after intra-intestinal or oral administration to that obtained after intravenous injection. Statistical evaluations were performed using the Student t-test. Differences with a p-value less than 0.05 were considered significant. This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Degradation of rHV2 in the GI contents and mucosa. The degradation of rHV2 in the GI contents is given in figure 1 . As we can see, 125 I-rHV2 rapidly degraded to the TCA-soluble form in the gastric contents and small-intestinal contents. The residual percentages of 125 I-rHV2 in the GI contents are summarized in table 1. The maximal degrading activity is in the stomach, only 27.04% 125 I-rHV2 remained after 30 min of degradation. The degrading activity in distal ileum is almost the same as in stomach, while those in jejunum and proximal ileum are much lower. Some adjuvant could inhibit the degradation, especially bacitracin and casein, with the residual percentage of hirudin of 62% and 58%, respectively. Table 1 also shows the degrading activity in the intestinal mucosa. Degrading activity in sub-fraction of the intestinal mucosa is nearly the same as in GI contents, except that the activity in cytosal fraction is a little lower than other parts of sub-fraction.
There was no site difference through the entire small intestine. In vitro everted sac experiment. To clarify the transport mechanism of rHV2 across the GI tract, we examined the effect of variant inhibitors on the uptake and transport of rHV2 across the jejunal mucosa. The results are summarized in table 2. The transport of rHV2 to the serosal side was significantly inhibited by low temperature, DNP (an uncoupler of oxidative phosphorylation), Carbopol 941 (a polyanion) and colchicines (an inhibitor of microtubular assembly), but not by poly-L-lysine (a polycation). The amount of rHV2 found in the intestinal tissue was also decreased, and the total amount of rHV2 taken in and transported across the GI tract tended to be inhibited by these treatments except for the addition of poly-L-lysine. This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
Chang demonstrated that hirudin is a very stable compound, it may be irreversibly denatured unless under elevated temperatures in alkaline solution (Chang JY, 1991) .
Wang also proved that rHV2 remained its most of anticoagulation activity after incubated with trypsin, pepsin or chymotrypsin (Wang et al., 1995) , but it can be degraded by pepsin. In above-mentioned studies only one kind of protease acts with hirudin in each experiment, however the effects of various digestive enzymes in GI tract should be more complex, especially in small intestine. Therefore, the luminal contents and mucosal subcellular fractions were used in our investigation in order to simulate the complicated surroundings in GI tract.
It was indicated from the degradation experiments that rHV2 was degraded rapidly by the GI tract luminal contents and mucosal subcellular fraction. The rHV2 concentration decreased below 50% of the initials within 30 min. The significant inhibitory effects of bacitracin and casein on rHV2 degradation have also been noticed.
Xian reported that casein can protect IGF-I from degradation in the stomach or duodenal flushing, but the mechanisms of this protection are not clear (Xian et al., 1995) . The inhibitory effect of HP-β-CD and SDCh are relatively weak compared with bacitracin and casein, though some studies suggested that DM-β-CD and SDCh have the ability of inhibiting the enzyme activities (Lars and Helle, 1995; Kakemi et al., 1970) . Anyhow it seems possible to use some protease inhibitors to protect rHV2 from the degradation by digestive enzymes in GI tract.
The bioavailability of oral administration of 125 I-rHV2 in rats is 21.23±3.73% estimated by TCA-precipitable method, which is not consistent with the value of This article has not been copyedited and formatted. The final version may differ from this version.
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TCA-precipitable method is more sensitive and could prove the transport of the intact rHV2 molecules into the body circulation, while the chromogenic assay could demonstrate at least the absorption of biologically active segments of rHV2 molecules into the blood of the animals. When co-administration of rHV2 with bacitracin or casein, the bioavailability was increased markedly, no matter which of the two analytical methods was applied.
As we can see from the results of in situ loop, the absorption of rHV2 is more slowly than oral administration. That may be related to the way of administration and the state of animals. In the perfusion process, the drug solution was pumped into intestinal tract slowly, while in the study of oral administration the drug solution was administered very rapidly. Another reason might be that the animals used in the in situ loop experiment were under anesthesia and their systemic circulation is much more slow than that of the normal states (Holzer et al., 2003) . Therefore, the absorption of drug in the in situ loop experiment was also slow. On the other hand, no significant differences in the rHV2 absorption among different parts of small intestine were found, suggesting that rHV2 has no preference on the absorption sites. Co-administration with bacitracin or casein could attain a small increment in bioavailability of rHV2, possibly due to the fact that intestinal tract was washed well and cleared of most digestive enzymes before perfusion studies. suggested that the transport was energy depended, so the transport routine may be related to transcellular way. The polylysine was reported to bind anionic sites of gall bladder epithelial cell membranes, thereby producing morphological changes such as collapse of the microvillar structure, membrane folding from the apical border into the terminal web, or 'fused' membranes with pentalaminar substructure (Quinton and Phillpot, 1973) .
These changes limited the absorption by transcellular way. Madara reported that polylysine could interact with anionic components of the glycoproteins on the surface of the epithelial cells (Madara JL, 1989) . Moreover, the interiors of the tight junction (pores) are highly hydrated and negative charged. An alteration in the relative concentration of specific ion species in the pore would result in substantial changes in tight junction resistance, which might lead to loosening or opening of the pore and enhancing the absorption by paracellular routine.
Presuming rHV2 was absorbed by endocytosis, the transcellular way would be blocked whereas the paracellular routine opened after polylysine was added. These two adverse effects on the epithelial cells would result in no increase of the rHV2 transport.
Polysine and rHV2 are being oppositely charged and might interact with each other, so the amount of transport of rHV2 in the mucosal tissue has a little decrease. The results of our experiments are consistent with above presumption, so it seems logical to deduce that rHV2 was absorbed mainly by endocytosis.
The transport of rHV2 was inhibited by DNP and cholchicine. DNP is an uncoupler of oxidative phosphorylation, while colchicine is an inhibitor of microtubular assembly. It was reported that carbopol showed a clear effect on opening of intercellular junctions, thereby enhancing the paracellular permeability for hydrophilic macromolecules (Luesen et al., 1996) . Carbopol also displays strong mucoadhesive properties (Bai et al., 1995; Mortazavi SA, 1995) and may therefore be able to localize its enzyme inhibiting and absorption enhancing activities to a confined area in the intestinal tract. However, it was showed in this study that carbopol inhibited the rHV2 transport.
The possible reason is that a stagnant layer formed by a highly viscous carbopol solution and repellence between both negatively charged carbopol and rHV2 may prevent rHV2 molecules from getting close to epithelial cell membrane, thus leading to the decrease of transport of rHV2 cross the membrane.
Toshikaro demonstrated that rhIGF-I could be absorbed into systemic circulation (Toshikiro et al., 1996) . The molecular weight of rhIGF-I is 7000 Da, which is almost equal to that of rHV2. The transport mechanism of rhIGF-I was inferred to be absorptive-mediated endocytosis. It was supposed from above results that rHV2 has the similar absorption mechanism as rhIGF-I, i.e. endocytosis might be the main route by which rHV2 molecules were absorbed into the circulation.
In conclusion, the maximum degradation was found in the stomach and distal ileum, slightly high than that in proximal ileum, jejunum and mucosal sub-fraction. Some enzyme inhibitor like bacitracin or casein could inhibit the degradation to certain degree.
The bioavilability after oral administration of rHV2 to rats varies obviously, dependent on the analytical method, and some of the enzyme inhibitor could enhance the rHV2 oral absorption. There is no site difference on rHV2 absorption in different segments of small intestine. The possible transport mechanism of rHV2 across the GI tract is concerned This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version.
